Equities

Sunshine Guojian Pharmaceutical Shanghai Co Ltd

688336:SHH

Sunshine Guojian Pharmaceutical Shanghai Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)24.86
  • Today's Change-0.07 / -0.28%
  • Shares traded3.03m
  • 1 Year change+7.53%
  • Beta--
Data delayed at least 15 minutes, as of Nov 12 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments1,7672,4652,260
Total Receivables, Net137158269
Total Inventory195227210
Prepaid expenses372427
Other current assets, total114112105
Total current assets2,2502,9862,872
Property, plant & equipment, net1,5981,5121,427
Goodwill, net0.640.640.64
Intangibles, net285310294
Long term investments1,020109122
Note receivable - long term------
Other long term assets5.945.945.94
Total assets5,3055,0984,889
LIABILITIES
Accounts payable221616
Accrued expenses1605252
Notes payable/short-term debt501500
Current portion long-term debt/capital leases------
Other current liabilities, total76157147
Total current liabilities308375215
Total long term debt000
Total debt501500
Deferred income tax------
Minority interest(18)(6.32)(2.46)
Other liabilities, total118124134
Total liabilities409493347
SHAREHOLDERS EQUITY
Common stock617617616
Additional paid-in capital2,3032,3092,301
Retained earnings (accumulated deficit)1,9851,6911,641
Treasury stock - common------
Unrealized gain (loss)(10)(12)--
Other equity, total1.591.15(17)
Total equity4,8964,6064,542
Total liabilities & shareholders' equity5,3055,0984,889
Total common shares outstanding617617616
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.